---
figid: PMC7952251__IJMM-47-05-04906-g01
figtitle: Regulatory mechanism of aromatase and '2-cell, 2-gonadotropin hypothesis'
organisms:
- Bos taurus
- Sus scrofa
- Equus caballus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Leonurus japonicus
organisms_ner:
- Sus scrofa
- Mus musculus
- Bos taurus
- Equus caballus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC7952251
filename: IJMM-47-05-04906-g01.jpg
figlink: pmc/articles/PMC7952251/figure/f2-ijmm-47-05-04906/
number: F2
caption: Regulatory mechanism of aromatase and '2-cell, 2-gonadotropin hypothesis'.
  The left panel illustrates that follicles are mainly composed of oocytes, granulosa
  cells and theca cells. Androstenedione and androsterone secreted by theca cells
  penetrate into granulosa cells and are converted into estrone and estradiol by the
  aromatase in granulosa cells under the stimulation of FSH and LH hormones. A small
  part acts on the ovaries, and the majority is released into the blood, collectively
  referred to as the '2-cell, 2-gonadotropin hypothesis'. The right panel mainly introduces
  the regulatory mechanism of aromatase in granulosa cells. FSH and LH bind to receptors
  and regulate CYP19A1 through PKA pathway. At the same time, IGF-1 binds to its receptor
  to activate PI3K/Akt, which upregulates the expression of CYP19; T3 cooperates with
  FSH also to acts on aromatase via PI3K/AKT pathway. The inhibition of the hormone-stimulated
  ERK with PD98059 can act on c-fos, causing the upregulation of CYP19 and the downregulation
  of CYP17. LH, luteinizing hormone; FSH, follicle-stimulating hormone; ERK, extracellular
  signal-regulated kinase; PI3K, phosphoinositide 3-kinase; PKA, protein kinase A;
  cAMP, cyclic adenosine monophosphate; CEBPB, CCAAT/enhancer-binding protein beta.
papertitle: 'Estrogen disorders: Interpreting the abnormal regulation of aromatase
  in granulosa cells (Review).'
reftext: Ting Liu, et al. Int J Mol Med. 2021 May;47(5):73.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9627823
figid_alias: PMC7952251__F2
figtype: Figure
redirect_from: /figures/PMC7952251__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7952251__IJMM-47-05-04906-g01.html
  '@type': Dataset
  description: Regulatory mechanism of aromatase and '2-cell, 2-gonadotropin hypothesis'.
    The left panel illustrates that follicles are mainly composed of oocytes, granulosa
    cells and theca cells. Androstenedione and androsterone secreted by theca cells
    penetrate into granulosa cells and are converted into estrone and estradiol by
    the aromatase in granulosa cells under the stimulation of FSH and LH hormones.
    A small part acts on the ovaries, and the majority is released into the blood,
    collectively referred to as the '2-cell, 2-gonadotropin hypothesis'. The right
    panel mainly introduces the regulatory mechanism of aromatase in granulosa cells.
    FSH and LH bind to receptors and regulate CYP19A1 through PKA pathway. At the
    same time, IGF-1 binds to its receptor to activate PI3K/Akt, which upregulates
    the expression of CYP19; T3 cooperates with FSH also to acts on aromatase via
    PI3K/AKT pathway. The inhibition of the hormone-stimulated ERK with PD98059 can
    act on c-fos, causing the upregulation of CYP19 and the downregulation of CYP17.
    LH, luteinizing hormone; FSH, follicle-stimulating hormone; ERK, extracellular
    signal-regulated kinase; PI3K, phosphoinositide 3-kinase; PKA, protein kinase
    A; cAMP, cyclic adenosine monophosphate; CEBPB, CCAAT/enhancer-binding protein
    beta.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FSH
  - FSHR
  - LHCGR
  - IGF1
  - IGF1R
  - SMAD2
  - PRKACA
  - AKT1
  - CYP19A1
  - CYP19A2
  - FOS
  - CEBPB
  - CYP17A1
  - Fshb
  - Fshr
  - Lhcgr
  - Acvr1b
  - ac
  - Igf1
  - Igf1r
  - Pik3r1
  - Smad2
  - Akt1
  - Cyp19a1
  - Fos
  - Ephb2
  - Mapk1
  - Mdk
  - Tlr4
  - Cebpb
  - Cyp17a1
  - PIK3CB
  - BRD2
  - CGA
  - FSHB
  - INHBA
  - INHBB
  - LHB
  - CD44
  - ACVR1B
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACB
  - PRKACG
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - IRF6
  - Pik3cg
  - Ephb1
  - fs(1)h
  - Lgr1
  - Actbeta
  - lh
  - Lhr
  - .na.character
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Smox
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Akt
  - kay
  - Erk7
  - rl
  - Dsor1
  - Mtk
  - fshr
  - lhcgr
  - igf1
  - smad2
  - cyp19a1a
  - cyp19a1b
  - fosab
  - cebpb
  - cyp17a1
  - Androstenedione
  - Estradiol
  - Testosterone
  - PD98059
  - LPS
---
